Search
Close this search box.

How a Healthy Lifestyle Can Reduce Genetic Risk for Early Death by 62%

Living a healthy lifestyle can have a significant impact on reducing the risk of early death, even for individuals with...

Maintaining a healthy lifestyle is not only important for overall well-being, but new research suggests it may also play a...

The Food and Drug Administration (FDA) has recently approved an Investigational New Drug (IND) application for VYN202, a novel BD2-selective...

The Indian Pharmacopoeia Commission (IPC) and the Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTech) have recently announced...

A recent Phase 2 clinical trial of the lead NOX inhibitor candidate, setanaxib, has shown promising results in the treatment...

The Food and Drug Administration (FDA) has recently approved Myhibbin (mycophenolate mofetil) oral suspension for the prevention of organ rejection...

BioPharma Services, a leading contract research organization (CRO) specializing in early-phase clinical trials, has recently announced that they have received...

The Association of Clinical Research Professionals (ACRP) recently released its 2024 report, highlighting the challenges faced by the clinical research...

The Association of Clinical Research Professionals (ACRP) recently released a report titled “ACRP 2024: Workforce and Patient Engagement in Clinical...

A recent Phase 2 clinical trial has shown promising results for the use of Erleada in combination with androgen deprivation...

Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma that typically affects older adults. While advancements...

Endometriosis is a common yet often misunderstood condition that affects millions of women worldwide. It occurs when tissue similar to...

A recent study has revealed promising results that suggest blood pressure medication may not only help lower blood pressure, but...

Amolyt Pharma, a biopharmaceutical company focused on developing innovative treatments for rare endocrine and metabolic diseases, recently announced that the...

The Environmental Protection Agency (EPA) has recently announced a significant allocation of $3 billion for the nationwide replacement of lead...

A new vaccine has shown promising results in protecting against a drug-resistant superbug in mice, according to a recent study...

Clinical research professionals play a crucial role in the development of new treatments and therapies for cancer patients. As part...

A recent study published in the journal Obesity has found that when it comes to weight loss, the number of...

When conducting a research study, selecting appropriate endpoints is crucial in order to accurately measure the outcomes of the study....

A promising new development has emerged in the field of cancer treatment, specifically for patients with B-cell lymphoma. The Phase...

The clinical trials industry plays a crucial role in the development of new medical treatments and therapies. In recent years,...

Summer camp can be a fun and exciting experience for children, but for those with allergies and asthma, it can...

Clinical trials are a crucial component of the medical research process, helping to determine the safety and effectiveness of new...

HealthTech, or healthcare technology, has revolutionized the way clinical trials are conducted in the medical field. With the integration of...

In the world of healthcare and clinical research, the use of technology has become increasingly important in collecting and analyzing...

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 15% of all...

Relyvrio, a controversial drug used to treat ALS (amyotrophic lateral sclerosis), is being pulled off the market by its maker,...

A groundbreaking Phase 2a clinical trial of regenerative cell therapy for end-stage liver disease has recently begun, with the first...

Wet age-related macular degeneration (AMD) is a chronic eye disease that can cause severe vision loss in older adults. It...

A new study published in Drugs.com MedNews has shown promising results for a transdermal microporation system using zolmitriptan in the...

How IPC’s Pharmacovigilance Programmes Support CDSCO & Pharmexcil Efforts to Enhance Patient Safety

Pharmacovigilance is a crucial aspect of the healthcare industry that focuses on monitoring and assessing the safety of pharmaceutical products. The Indian Pharmacopoeia Commission (IPC) plays a significant role in ensuring the safety of drugs through its pharmacovigilance programmes. These programmes support the efforts of the Central Drugs Standard Control Organization (CDSCO) and the Pharmaceuticals Export Promotion Council of India (Pharmexcil) in enhancing patient safety.

The CDSCO is the regulatory authority responsible for approving and monitoring pharmaceutical products in India. It plays a vital role in ensuring that drugs meet quality standards and are safe for consumption. However, despite rigorous testing and approval processes, adverse drug reactions (ADRs) can still occur once a drug is on the market. This is where pharmacovigilance comes into play.

Pharmacovigilance programmes aim to detect, assess, understand, and prevent ADRs associated with pharmaceutical products. By collecting and analyzing data on ADRs, healthcare professionals can identify potential risks and take appropriate measures to protect patients. IPC’s pharmacovigilance programmes provide valuable support to CDSCO by helping to monitor the safety of drugs in the market and identify any emerging safety concerns.

In addition to supporting CDSCO, IPC’s pharmacovigilance programmes also play a crucial role in supporting Pharmexcil’s efforts to enhance patient safety. Pharmexcil is an organization that promotes the export of pharmaceutical products from India to international markets. Ensuring the safety and quality of these products is essential for maintaining India’s reputation as a reliable supplier of pharmaceuticals.

By participating in IPC’s pharmacovigilance programmes, pharmaceutical companies can demonstrate their commitment to patient safety and quality assurance. Through these programmes, companies can report any ADRs associated with their products, which helps to ensure that potential risks are identified and addressed promptly. This not only protects patients but also helps to maintain the credibility of Indian pharmaceutical products in the global market.

Overall, IPC’s pharmacovigilance programmes play a vital role in supporting CDSCO and Pharmexcil’s efforts to enhance patient safety. By monitoring and assessing the safety of pharmaceutical products, these programmes help to identify and prevent potential risks, ultimately ensuring that patients receive safe and effective treatments. Pharmaceutical companies are encouraged to actively participate in these programmes to contribute to the overall goal of improving patient safety in India and beyond.